Star Voyage International Limited and Xuncheng Chen are reported as holding 9.94% of Universe Pharmaceuticals, equal to 497,917 Class A ordinary shares. For investors, the key distinction is the holders’ stated passive intent: the securities were not acquired or held to change or influence the company’s control.
Key Highlights
- Star Voyage International reported beneficial ownership of 497,917 Class A ordinary shares.
- The reported position represents 9.94% of Universe Pharmaceuticals INC’s Class A ordinary shares.
- The filing states the securities were not acquired or held to change or influence control.
The reporting persons state that the securities were not acquired or held to change or influence control.
Ownership Structure and Share Count
The ownership report attributes the same 497,917 Class A ordinary shares and 9.94% interest to Chen. Universe Pharmaceuticals INC (NASDAQ: UPC) is identified as a Cayman Islands exempted company.
Passive Status Excludes Control-Change Purpose
The filing states that the securities were not acquired or held for the purpose or effect of changing or influencing control of Universe Pharmaceuticals INC.
FAQs
Q: Does Star Voyage’s UPC stake seek control?
A: No. The filing states that the securities were not acquired or held for the purpose or effect of changing or influencing Universe Pharmaceuticals INC’s control. It identifies the filing under Rule 13d-1(c).
Q: How many Universe Pharmaceuticals shares did Star Voyage report?
A: Star Voyage International reported ownership of 497,917 Class A ordinary shares. The filing states that these shares represented 9.94% of the class, based on 5,008,313 shares outstanding.
Q: Who wholly owns and controls Star Voyage International?
A: Xuncheng Chen wholly owns and controls Star Voyage International. The filing lists Chen as a reporting person with the same reported 497,917 shares and 9.94% ownership percentage.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.